220 results on '"Cassiman, David"'
Search Results
2. Rare monogenic causes of steatotic liver disease masquerading as MASLD
3. Disorders of Bile Acid Synthesis
4. Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease
5. Brain function in classic galactosemia, a galactosemia network (GalNet) members review
6. Aberrant N-glycosylation in pathogenic variants of adenosine deaminase 2 underlying human ADA2 deficiency
7. Quality of life of adult patients with hereditary fructose intolerance
8. Tracer metabolomics reveals the role of aldose reductase in glycosylation
9. Distinct immunometabolic signatures in circulating immune cells define disease outcomes in acute-on-chronic liver failure
10. Sequential BAVENO VI plus dedicated spleen stiffness measurement or a novel spleen-centered algorithm significantly enlarges non-invasive ruling out of high risk varices: results from an international derivation-validation cohort study
11. Plasma virome dynamics in chronic hepatitis B virus infected patients
12. Data from Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
13. Data from Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
14. Supplementary Information from Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
15. Supplementary Information from Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
16. Supplementary Data from A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma
17. Supplementary Data from A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma
18. Data from A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma
19. Data from A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma
20. Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol‐related liver disease
21. Measuring Rates of ATP Synthesis
22. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial
23. PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation
24. EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms
25. Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
26. Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias
27. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study
28. Ornithine transcarbamylase deficiency: A diagnostic odyssey
29. Uncovering monocyte transcription, functional and metabolic signatures in recovery and non-recovery ACLF patients
30. Clinical utility of non-ceruloplasmin copper determined by copper speciation for monitoring Wilson disease therapy: comparative data analysis with 24-hour urinary copper excretion from the CHELATE trial
31. Neurocognitive outcome and mental health in children with tyrosinemia type 1 and phenylketonuria: A comparison between two genetic disorders affecting the same metabolic pathway
32. Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives
33. A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge
34. CLINICAL AND BIOCHEMICAL FOOTPRINTS OF INHERITED METABOLIC DISORDERS: A LESSON FROM THE KNOWLEDGEBASE
35. Liver disorders
36. Tyrosinemia Type I
37. Glycogen Storage Disorders
38. Approach to the Patient with Hepato-Gastroenterological or Abdominal Signs and Symptoms
39. Overlapping and divergent hepatic and lipoprotein phenotypes in untreated adults with acid sphingomyelinase deficiency versus untreated adults with Gaucher disease from two pivotal clinical trials
40. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
41. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
42. Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series
43. Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications
44. Genotype-Phenotype Correlations in PMM2-CDG
45. Patents vs patients 1‐0: The case of chenodeoxycholic acid
46. S1063 Disease Burden in Patients With Acute Hepatic Porphyria: Experience From the Phase 3 ENVISION Study
47. Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease
48. Uncertain Diagnosis of Fabry Disease in Patients with Neuropathic Pain, Angiokeratoma or Cornea Verticillata: Consensus on the Approach to Diagnosis and Follow-Up
49. Expert consensus statement on acute hepatic porphyria in Belgium
50. Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.